Influenza Vaccines Market: Global Industry Analysis, Share, Size, Growth, Opportunity and Forecast 2019-2027

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

The global influenza vaccines market size is expected to surpass USD 6 billion by 2025.

"Influenza Vaccines Market: Global Industry Analysis, Share, Size, Growth, Opportunity and Forecast 2019-2025" presents an in-depth assessment of the global influenza vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for the global influenza vaccines market. The report includes historical data from 2013 to 2018 and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025.The report provides clear insight into current and future developments of the global influenza vaccines market. The report also explores a detailed analysis of the number of persons being vaccinated with influenza vaccines globally from 2013 to 2018 and forecasts to 2025.

Additionally, the report includes assessment of clinical trials, promising influenza vaccines in the clinical development and rapid diagnostic testing for the management of influenza. It also provides a deep and thorough evaluation of the distribution channel and technique of the influenza vaccination. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also explores the detailed description of growth drivers and inhibitors of the global influenza vaccines market.

Further, prudent analysis has been done on the competitor's part, where four major players grab a major share of the global influenza vaccine market by net sales. Sanofi Pasteur, GlaxoSmithKline (GSK), Seqirus (CSL Limited) and AstraZeneca are the key influencers with their vaccines in the global influenza vaccines market. Other emerging players such as Novavax, Daiichi-Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, Altimmune, FluGen, Moderna, Vaccitech, VaxInnate and BioDiem are making novel technology-based influenza vaccine which is likely to affect the market share during the forecast period.


The report concludes with the profiles of major players in the global influenza vaccines market. The key market players are evaluated on various parameters such as company overview, influenza vaccines portfolios, sales value analysis and recent development in the global influenza vaccines market.

The major and emerging companies dominating this market for its vaccines, services and continuous product developments are:

• Sanofi Pasteur
• GlaxoSmithKline (GSK)
• Seqirus (CSL Limited)
• AstraZeneca
• Mylan
• Sinovac Biotech Ltd.
• Gamma Vaccines Pty Ltd.
• Hualan Biological Engineering Inc.
• Shanghai Institute of Biological Products Co., Ltd.
• Novavax
• Daiichi-Sankyo
• Mitsubishi Tanabe Pharma
• BiondVax Pharmaceuticals Ltd
• Altimmune
• FluGen
• Moderna
• Vaccitech
• VaxInnate
• BioDiem

Twenty-One Major Markets (21MM) covered in the report are as follows:

• United States
• Canada
• Germany
• France
• Italy
• Spain
• United Kingdom
• Netherlands
• Sweden
• Denmark
• Poland
• Norway
• Finland
• Ireland
• Belgium
• Australia
• New Zealand
• Japan
• Brazil
• China
• India

The Latest Industry Data Included in this Report:

• Global Influenza Vaccines Market Size and Analysis (2013 - 2025)
• Global Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
• Global Influenza Vaccines Market Share Analysis and Forecast (2013 - 2025)
• Global Number of Persons Vaccinated with Influenza Vaccines Share and Forecast (2013 - 2025)
• Global Influenza Vaccines Market in Top 21 Countries and Forecast (2013 - 2025)
• Rapid Diagnostic Testing for the Management of Influenza
• Global Distribution Channel and Technique of Influenza Vaccination
• Promising Influenza Vaccines in Clinical Development
• Major Deals in the Global Influenza Vaccines Market
• Influenza Vaccines Clinical Trial Insights by Phase, Company & Country
• Market Definition for the Specified Topic Along with Identification of Key Drivers and Inhibitors for the Market
• A Comprehensive List of Key Market Players Along with the Analysis of their Current Vaccines Portfolios, Sales Value Analysis, and Recent Development

The Report Answers the Following Questions about the Global Influenza Vaccines Market:

• How has the global influenza vaccines market performed so far and how will it perform in the coming years?
• What are the key markets in the global influenza vaccines industry?
• How many numbers of persons being vaccinated with influenza vaccines globally during 2013 - 2025?
• What are the key drivers and inhibitors in the current market?
• What are the various influenza vaccines available globally?
• How is the market predicted to develop in the future?
• Who are the key players in this market space?

1. Executive Summary

2. Global Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)

3. Global Influenza Vaccines Market Size and Analysis (2013 - 2025)

4. Global Influenza Vaccines Market Share Analysis and Forecast (2013 - 2025)
4.1 Global Number of Persons Vaccinated with Influenza Vaccines Share and Forecast
4.2 Global Influenza Vaccines Market Share and Forecast

5. Key Drivers and Inhibitors of the Global Influenza Vaccines Market
5.1 Market Drivers
5.2 Market Inhibitors

6. Global Influenza Vaccines Market in Top 21 Countries - Geographical Landscape (Volume and Value) (2013 - 2025)
6.1 United States
6.1.1 United States Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.1.2 United States Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.2 Canada
6.2.1 Canada Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.2.2 Canada Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.3 Germany
6.3.1 Germany Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.3.2 Germany Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.4 France
6.4.1 France Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.4.2 France Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.5 Italy
6.5.1 Italy Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.5.2 Italy Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.6 Spain
6.6.1 Spain Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.6.2 Spain Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.7 United Kingdom
6.7.1 United Kingdom Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.7.2 United Kingdom Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.8 Netherlands
6.8.1 Netherlands Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.8.2 Netherlands Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.9 Sweden
6.9.1 Sweden Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.9.2 Sweden Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.10 Denmark
6.10.1 Denmark Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.10.2 Denmark Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.11 Poland
6.11.1 Poland Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.11.2 Poland Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.12 Norway
6.12.1 Norway Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.12.2 Norway Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.13 Finland
6.13.1 Finland Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.13.2 Finland Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.14 Ireland
6.14.1 Ireland Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.14.2 Ireland Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.15 Belgium
6.15.1 Belgium Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.15.2 Belgium Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.16 Australia
6.16.1 Australia Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.16.2 Australia Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.17 New Zealand
6.17.1 New Zealand Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.17.2 New Zealand Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.18 Japan
6.18.1 Japan Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.18.2 Japan Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.19 Brazil
6.19.1 Brazil Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.19.2 Brazil Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.20 China
6.20.1 China Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.20.2 China Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.21 India
6.21.1 India Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.21.2 India Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.22 Other Countries
6.22.1 Other Countries Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.22.2 Other Countries Influenza Vaccines Market Size & Analysis (2013 - 2025)

7. Rapid Diagnostic Testing for the Management of Influenza

8. Global Distribution Channel and Technique of Influenza Vaccination

9. Promising Influenza Vaccines in Clinical Development

10. Major Deals in the Global Influenza Vaccines Market
10.1 Merger& Acquisitions
10.2 Collaboration Deal
10.3 Licensing Agreement
10.4 Exclusive Agreement
10.5 Distribution Agreement

11. Influenza Vaccines Clinical Trial Insights by Phase, Company & Country
11.1 Year 2018
11.2 Year 2017

12. Key Companies Analysis
12.1 Sanofi Pasteur
12.1.1 Business Overview
12.1.2 Influenza Vaccines Portfolio
12.1.3 Influenza Vaccine Value Sales Analysis
12.1.4 Recent Development
12.2 GlaxoSmithKline (GSK)
12.2.1 Business Overview
12.2.2 Influenza Vaccines Portfolio
12.2.3 Influenza Vaccine Sales Value Analysis
12.2.4 Recent Development
12.3 Seqirus (CSL Limited)
12.3.1 Business Overview
12.3.2 Influenza Vaccines Portfolios
12.3.3 Recent Development
12.4 AstraZeneca
12.4.1 Business Overview
12.4.2 Influenza Vaccines Portfolio
12.4.3 Influenza Vaccine Sales Value Analysis
12.4.4 Recent Development
12.5 Sinovac Biotech Ltd.
12.5.1 Business Overview
12.5.2 Influenza Vaccines Portfolio
12.5.3 Influenza Vaccine Sales Value Analysis
12.5.4 Recent Development
12.6 Gamma Vaccines Pty Ltd
12.6.1 Business Overview
12.6.2 Influenza Vaccines Portfolio
12.6.3 Recent Development
12.7 Hualan Biological Engineering Inc
12.7.1 Business Overview
12.7.2 Influenza Vaccines Portfolio
12.7.3 Recent Development
12.8 Shanghai Institute of Biological Products Co., Ltd.
12.8.1 Business Overview
12.8.2 Influenza Vaccine Portfolio
12.9 Mylan
12.9.1 Business Overview
12.9.2 Influenza Vaccine Portfolio
12.10 BioDiem
12.10.1 Business Overview
12.10.2 Influenza Vaccine Portfolio
12.10.3 Recent Development

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 1001 4th Ave, #3200 Seattle, WA 98154, U.S.

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports 203, 2nd Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).

Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2020 Worldwide Market Reports. All rights reserved